newsfilter
← Latest News
GlobeNewswire·

Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis

MALVERN, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (NASDAQ:GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary